Glutathione: Complete Research Guide & Chemical Profile

Glutathione (gamma-L-glutamyl-L-cysteinyl-glycine) is a tripeptide with the molecular formula C10H17N3O6S and a molecular weight of 307.32 Da. The defining structural feature is the gamma-peptide bond between the gamma-carboxyl group of glutamate and the amino group of cysteine, rather than the conventional alpha-peptide bond. This gamma linkage renders glutathione resistant to cleavage by most intracellular peptidases and is hydrolyzed only by the ectoenzyme gamma-glutamyl transpeptidase (GGT) on the external cell surface.

The cysteine residue provides the thiol (-SH) functional group that is responsible for the redox and nucleophilic chemistry of glutathione. The thiol pKa is approximately 9.2, meaning that only a small fraction (~1%) exists as the reactive thiolate anion (GS-) at physiological pH 7.4. However, enzyme active sites (glutathione peroxidase, glutathione S-transferase) lower the effective pKa through electrostatic stabilization, dramatically enhancing thiolate reactivity in catalytic contexts. The reduced form (GSH) vastly predominates over the oxidized disulfide form (GSSG) under normal conditions, with a typical GSH:GSSG ratio of 100:1 to 300:1 in the cytoplasm.

Glutathione exists as a white crystalline powder in its reduced form (GSH) and is freely soluble in water. The compound is stable as a lyophilized powder at -20 degrees Celsius but undergoes oxidation to GSSG in aqueous solution at neutral pH when exposed to air, metal ions, or elevated temperature. Research preparations should be made fresh or stored under inert gas (nitrogen or argon) with metal chelators (EDTA or DTPA) to minimize auto-oxidation. The UV absorbance of GSH is minimal at 280 nm; the thiol group absorbs weakly at 215 nm.

• Full name: gamma-L-Glutamyl-L-cysteinyl-glycine
• Abbreviation: GSH (reduced), GSSG (oxidized disulfide)
• Molecular formula: C10H17N3O6S (GSH)
• Molecular weight: 307.32 Da (GSH), 612.63 Da (GSSG)
• CAS number: 70-18-8 (GSH)
• Key bond: Gamma-peptide linkage (Glu gamma-COOH to Cys alpha-NH2)
• Thiol pKa: ~9.2
• Intracellular concentration: 1-10 mM (tissue-dependent)

Glutathione biosynthesis is a two-step ATP-dependent process catalyzed by cytoplasmic enzymes. In the first and rate-limiting step, glutamate-cysteine ligase (GCL, formerly gamma-glutamylcysteine synthetase) catalyzes the formation of gamma-glutamylcysteine from L-glutamate and L-cysteine, consuming one ATP. GCL is a heterodimer composed of a catalytic subunit (GCLC, ~73 kDa) and a modifier subunit (GCLM, ~31 kDa). The catalytic subunit contains the active site, while the modifier subunit lowers the Km for glutamate and raises the Ki for GSH feedback inhibition, increasing overall catalytic efficiency.

In the second step, glutathione synthetase (GS) catalyzes the addition of glycine to the C-terminus of gamma-glutamylcysteine, consuming a second ATP to generate the completed tripeptide GSH. GS is a homodimer of ~52 kDa subunits and is generally not rate-limiting under physiological conditions. The total GSH biosynthetic cost is 2 ATP per GSH molecule. The availability of L-cysteine is typically the rate-limiting substrate, as intracellular cysteine concentrations (~100 micromolar) are well below the Km of GCL for cysteine (~200-300 micromolar).

GSH is exported from the cell and degraded on the external cell surface by gamma-glutamyl transpeptidase (GGT), which transfers the gamma-glutamyl group to amino acid acceptors. The resulting cysteinyl-glycine dipeptide is cleaved by membrane dipeptidases to release free cysteine and glycine for reuptake. This extracellular degradation and amino acid recycling pathway constitutes the gamma-glutamyl cycle (Meister cycle), which allows GSH to serve as a vehicle for cysteine transport and inter-organ amino acid trafficking, particularly cysteine delivery from the liver to peripheral tissues.

The GSH/GSSG redox couple is the most abundant thiol-disulfide system in the cell and establishes the baseline redox potential of the intracellular environment. The Nernst equation applied to the GSH/GSSG couple (standard reduction potential E0 = -240 mV) yields cytoplasmic redox potentials of approximately -220 to -240 mV in proliferating cells, -200 mV in differentiating cells, and -170 mV or higher in cells undergoing apoptosis. These redox potential shifts modulate the activity of redox-sensitive enzymes and transcription factors.

Under oxidative stress, GSH is consumed by glutathione peroxidases (GPx) during the reduction of hydrogen peroxide and lipid hydroperoxides to water and the corresponding alcohols. The resulting GSSG is recycled back to GSH by glutathione reductase (GR), which uses NADPH as the electron donor. This regeneration cycle links GSH homeostasis to the pentose phosphate pathway (the primary source of cytoplasmic NADPH) and to mitochondrial NADPH production via nicotinamide nucleotide transhydrogenase and isocitrate dehydrogenase 2.

When oxidative stress overwhelms the GR recycling capacity, GSSG accumulates and the GSH:GSSG ratio decreases. GSSG can be exported from the cell via MRP1/ABCC1 (multidrug resistance-associated protein 1) to prevent toxic intracellular accumulation. However, GSSG export represents a net loss of glutathione from the cell, requiring de novo synthesis to restore GSH pools. Persistent GSH depletion below approximately 70% of normal levels triggers oxidative damage cascading through protein thiol oxidation, lipid peroxidation, and DNA oxidative damage.

Glutathione participates in ROS detoxification through both enzymatic and non-enzymatic mechanisms. The glutathione peroxidase (GPx) family comprises eight selenium-dependent and non-selenium isoforms that reduce hydrogen peroxide, lipid hydroperoxides, and phospholipid hydroperoxides using GSH as the reducing substrate. GPx1 (cytoplasmic) and GPx4 (phospholipid hydroperoxide glutathione peroxidase, essential for preventing ferroptosis) are the most extensively studied family members.

Non-enzymatic scavenging by GSH provides a direct chemical defense against reactive oxygen and nitrogen species. GSH reacts with superoxide anion, hydroxyl radical, singlet oxygen, peroxynitrite, and nitrogen dioxide at diffusion-limited or near-diffusion-limited rates. The millimolar intracellular concentration of GSH ensures that these non-enzymatic reactions are quantitatively significant despite modest second-order rate constants. The resulting glutathionyl radical (GS radical) and other intermediates are recycled through enzymatic and non-enzymatic pathways.

Glutathione also regenerates other antioxidants through coupled redox cycling. GSH reduces dehydroascorbate back to ascorbate (vitamin C) via the enzyme dehydroascorbate reductase and non-enzymatic thiol-disulfide exchange. This ascorbate-glutathione cycle connects the water-soluble antioxidant network, with NADPH ultimately providing the reducing equivalents through GR. Similarly, glutathione interacts with the thioredoxin system through glutaredoxin-mediated reactions, creating an interconnected antioxidant network with multiple redundancies.

Glutathione S-transferases (GSTs) catalyze the conjugation of GSH to electrophilic substrates including xenobiotics, drugs, environmental pollutants, and endogenous reactive metabolites. The human GST superfamily comprises cytoplasmic (alpha, mu, pi, theta, sigma, omega, zeta classes), mitochondrial (kappa class), and membrane-bound (MAPEG family) isoforms. GST-catalyzed conjugation neutralizes electrophilic centers by forming thioether (GS-R) bonds, rendering the conjugates more water-soluble for subsequent excretion.

GSH conjugates formed by GSTs are exported from the cell via MRP/ABCC transporters and further metabolized in the extracellular space through the mercapturic acid pathway. GGT removes the gamma-glutamyl group, dipeptidases remove glycine, and the resulting cysteine conjugate is N-acetylated by N-acetyltransferases in the kidney to form a mercapturic acid (N-acetylcysteine conjugate) that is excreted in urine. Urinary mercapturic acids serve as biomarkers of glutathione-dependent xenobiotic detoxification and electrophilic stress.

Endogenous substrates for GSH conjugation include 4-hydroxynonenal (4-HNE) and other lipid peroxidation products, leukotriene A4 (forming leukotriene C4 via LTC4 synthase, a MAPEG family member), and prostaglandin intermediates. The conjugation of 4-HNE by GSTA4 is particularly important for protection against lipid peroxidation-mediated damage. Depletion of GSH below the capacity to maintain these conjugation reactions exposes cells to the cytotoxic effects of accumulated electrophilic metabolites.

Beyond its antioxidant functions, glutathione participates in redox signaling through protein S-glutathionylation, the reversible formation of mixed disulfides between protein cysteine residues and GSH. S-glutathionylation serves as a post-translational modification analogous to phosphorylation, modifying protein activity, localization, and interactions in response to oxidative signals. Over 2,000 proteins have been identified as S-glutathionylation targets, including kinases (IKKbeta, JNK, Src), phosphatases (PTP1B, PTEN), and metabolic enzymes.

The transcriptional regulation of the GSH biosynthetic machinery is coordinated by the Nrf2/Keap1/ARE (nuclear factor erythroid 2-related factor 2/Kelch-like ECH-associated protein 1/antioxidant response element) pathway. Under basal conditions, Keap1 targets Nrf2 for proteasomal degradation through CUL3 ubiquitin ligase. Electrophilic or oxidative stress modifies reactive cysteine residues on Keap1 (particularly Cys151, Cys273, and Cys288), disrupting the Keap1-Nrf2 interaction and allowing Nrf2 nuclear translocation. Nuclear Nrf2 activates ARE-driven transcription of GCLC, GCLM, GS, GPx2, GR, and multiple GST isoforms.

The redox-sensitive transcription factor NF-kappaB is also modulated by glutathione status. GSH depletion promotes NF-kappaB activation through enhanced IKK activity and increased nuclear translocation of p65/RelA, while GSH repletion suppresses NF-kappaB signaling. This redox regulation creates a bidirectional relationship between glutathione status and inflammatory gene expression: oxidative stress depletes GSH, activating NF-kappaB-driven inflammation, which generates further oxidative stress in a feed-forward cycle. Breaking this cycle through GSH repletion represents a research strategy for inflammatory conditions.

N-acetylcysteine (NAC) is the most widely used pharmacological agent for enhancing intracellular glutathione levels. NAC (molecular formula C5H9NO3S, MW 163.19 Da) is the N-acetylated derivative of L-cysteine that is deacetylated intracellularly by aminoacylase enzymes to release free L-cysteine, the rate-limiting substrate for GSH biosynthesis. The N-acetyl group protects the cysteine thiol from oxidation during absorption and transport, improving bioavailability compared to free L-cysteine.

In research applications, NAC at concentrations of 1-10 mM in cell culture or 150-300 mg/kg in rodent studies effectively increases intracellular GSH levels within 2-4 hours. NAC also possesses direct antioxidant activity independent of GSH synthesis, as the free thiol can directly scavenge hypochlorous acid (HOCl), hydroxyl radical, and nitrogen dioxide. Additionally, NAC acts as a reducing agent that can break disulfide bonds in extracellular proteins, a property exploited clinically as a mucolytic agent. The direct antioxidant and GSH precursor activities of NAC are difficult to separate experimentally without using GCL inhibitors such as buthionine sulfoximine (BSO).

Alternative GSH precursors used in research include gamma-glutamylcysteine (the direct GCL product, bypassing the rate-limiting step), glycine supplementation (relevant when glycine is co-limiting), and alpha-lipoic acid (which increases cysteine availability through reduction of cystine to cysteine at the cell surface). S-adenosylmethionine (SAMe) supports GSH synthesis indirectly through the transsulfuration pathway by converting homocysteine to cysteine. Each precursor strategy addresses a different rate-limiting step and may be more or less effective depending on the specific metabolic context.

The delivery of exogenous GSH faces significant bioavailability challenges. Oral GSH is hydrolyzed by GGT and dipeptidases in the intestinal brush border before absorption, and first-pass hepatic metabolism further limits systemic availability. Clinical pharmacokinetic studies of oral GSH supplementation have shown minimal or no increase in plasma GSH levels at standard doses. The constituent amino acids (glutamate, cysteine, glycine) are absorbed and can serve as GSH biosynthetic substrates, but this is functionally equivalent to amino acid supplementation rather than direct GSH delivery.

Intravenous (IV) GSH administration bypasses intestinal and hepatic first-pass barriers, achieving direct plasma concentration increases. However, circulating GSH is rapidly cleared by hepatic and renal uptake and extracellular degradation by GGT, with a plasma half-life of approximately 2-3 minutes. The rapid clearance necessitates continuous infusion or repeated bolus dosing to maintain elevated plasma levels. IV GSH has been used in research settings to investigate the effects of acute GSH elevation on vascular function, insulin sensitivity, and hepatic detoxification capacity.

Liposomal GSH encapsulates reduced glutathione within phospholipid vesicles, protecting it from intestinal degradation and potentially enhancing cellular uptake through membrane fusion or endocytosis. Some pharmacokinetic studies report improved oral bioavailability with liposomal formulations compared to unencapsulated GSH, with measurable increases in plasma and lymphocyte GSH levels. The liposomal delivery approach remains an active area of formulation research, with variables including vesicle size, phospholipid composition, PEGylation, and encapsulation efficiency all influencing in vivo performance.

Accurate measurement of GSH and GSSG requires careful sample handling to prevent artifactual oxidation of GSH to GSSG during processing. Rapid acid precipitation (5% metaphosphoric acid or 5% sulfosalicylic acid) immediately upon sample collection is essential to precipitate proteins and stabilize thiol status. The enzymatic recycling assay (Tietze assay) measures total glutathione (GSH + 2GSSG) by GR-mediated reduction of DTNB (5,5-dithio-bis-2-nitrobenzoic acid, Ellman reagent), producing TNB that absorbs at 412 nm. GSSG is measured separately after thiol masking with 2-vinylpyridine or N-ethylmaleimide, and GSH is calculated by difference.

HPLC-based methods offer improved specificity and sensitivity for GSH and GSSG quantification. Thiol derivatization with monobromobimane (mBBr), ortho-phthalaldehyde (OPA), or N-ethylmaleimide followed by reversed-phase HPLC with fluorescence or UV detection provides femtomole sensitivity. LC-MS/MS with stable isotope dilution (13C, 15N-labeled GSH internal standard) represents the gold standard for simultaneous GSH and GSSG quantification with minimal matrix interference. For redox potential calculations, both GSH concentration and the GSH:GSSG ratio must be determined accurately under artifact-free conditions.

The following publications represent key research on glutathione biochemistry, redox biology, and the roles of GSH in cellular defense and signaling.

• Read more: TRH (Thyrotropin-Releasing Hormone): Research Guide & Chemical Profile → https://www.chemverify.com/learn/trh-thyrotropin-releasing-hormone-research-guide
• Read more: Ipamorelin + CJC-1295 (No DAC) Stack: Synergy Research Guide → https://www.chemverify.com/learn/ipamorelin-cjc-1295-no-dac-stack-synergy
• Read more: TP508 (Chrysalin): Research Guide & Chemical Profile → https://www.chemverify.com/learn/tp508-chrysalin-research-guide-chemical-profile
• Read more: Semax for Cognitive Research: ACTH(4-10) Analog Mechanism → https://www.chemverify.com/learn/semax-cognitive-research-acth-mechanism